Inivata announces launch of clinical trial to evaluate impact of InVisionFirst®-Lung liquid biopsy test on time to appropriate treatment in advanced lung cancer

    NEXT STORY
    Clearside Biomedical Announces Multiple Oral Presentations to be Given at the American Society of Retinal Specialists (ASRS) Annual Meeting
    PREV STORY
    Teleflex Announces Second Quarter 2019 Earnings Conference Call Information 
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Aduro Biotech Provides Update on CRS-207 Programs

    BERKELEY, Calif., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    World Specialty Endoscopic Surgery Devices Market Outlook to 2023 – Includes Medical Device Product Portfolios Offered by Leading Manufacturers & Procedure Volumes for Specialty Endoscopic Surgeries

    author_avatar
    NASDAQ Market News

    Inovio Pharmaceuticals Reports 2017 Fourth Quarter and Year End Financial Results

    PLYMOUTH MEETING, Pa., March 14, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today ...

    author_avatar
    NASDAQ Market News